Then we found that MEG3 methylation in plasma was an effective biomarker for the diagnosis of CIN III (cervical intraepithelial neoplasia), HR-HPV (High risk-Human papillomavirus) infection and lymph node metastasis. This evidence concerns the gene MEG3 and metastatic malignant neoplasm in the lymph nodes.